IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | 1022 일 전
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | 573 일 전
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | 756 일 전
Taiwan Shares May Reverse Monday's Losses

Taiwan Shares May Reverse Monday's Losses

The Taiwan stock market on Monday wrote a finish to the eight-day winning streak in which it had surged more than 1,450 points or 5.8 percent. The Taiwan Stock Exchange now sits just above the 25,350-point plateau although it's expected to rebound on Tuesday.
RTTNews | 28 분 전
Singapore Bourse May Halt Losing Streak

Singapore Bourse May Halt Losing Streak

The Singapore stock market has moved lower in back-to-back sessions, slumping more than 15 points or 0.4 percent along the way. The Straits Times Index now sits just beneath the 4,340-point plateau although it may stop the bleeding on Tuesday.
RTTNews | 58 분 전
Win Streak May Continue For Japan Stock Market

Win Streak May Continue For Japan Stock Market

Ahead on Monday's holiday for Respect For The Aged Day, the Japanese stock market had moved higher in three straight sessions, rallying more than 1,300 points or 2.9 percent in that span. The Nikkei 225 now sits just beneath the 44,770-point plateau and it may add to its winnings again on Tuesday.
RTTNews | 1 시간 28 분 전
KOSPI Has Another Positive Lead For Tuesday

KOSPI Has Another Positive Lead For Tuesday

The South Korea stock market has moved higher in 10 straight sessions, surging more than 260 points or 8.3 percent along the way. Now at another fresh record closing high, the KOSPI sits just beneath the 3,410-point plateau and it's tipped to open in the green again on Tuesday.
RTTNews | 1 시간 58 분 전
South Korea Import, Export Price Data Due On Tuesday

South Korea Import, Export Price Data Due On Tuesday

South Korea will on Tuesday see August numbers for import and export prices, highlighting a light day for Asia-Pacific economic activity. In July, import prices were down 5.9 percent on year and export prices fell an annual 4.3 percent.
RTTNews | 2 시간 58 분 전
South Korea Export Prices Rise 0.7% In August

South Korea Export Prices Rise 0.7% In August

Export prices in South Korea were up a seasonally adjusted 0.7 percent on month in August, the Bank of Korea said on Tuesday - after adding 0.8 percent in July.
RTTNews | 3 시간 28 분 전